phytic acid has been researched along with Osteosarcoma in 5 studies
Phytic Acid: Complexing agent for removal of traces of heavy metal ions. It acts also as a hypocalcemic agent.
myo-inositol hexakisphosphate : A myo-inositol hexakisphosphate in which each hydroxy group of myo-inositol is monophosphorylated.
Osteosarcoma: A sarcoma originating in bone-forming cells, affecting the ends of long bones. It is the most common and most malignant of sarcomas of the bones, and occurs chiefly among 10- to 25-year-old youths. (From Stedman, 25th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "To explore the effect of phytic acid on the human osteosarcoma U20S cells and its mechanisms in vitro." | 7.78 | [Anti-tumor effect of phytic acid on human osteosarcoma U2OS cells in vitro]. ( Cheng, C; Cui, H; Wang, L; Zhao, H, 2012) |
| "Phytic acid (PA) is a natural compound extracted from plant seeds, which shows certain antitumor activity and good bone targeting ability." | 5.91 | Phytic acid-modified manganese dioxide nanoparticles oligomer for magnetic resonance imaging and targeting therapy of osteosarcoma. ( Ding, J; Fan, J; Hu, R; Huang, R; Ju, Q; Li, R; Zhang, D, 2023) |
| "To explore the effect of phytic acid on the human osteosarcoma U20S cells and its mechanisms in vitro." | 3.78 | [Anti-tumor effect of phytic acid on human osteosarcoma U2OS cells in vitro]. ( Cheng, C; Cui, H; Wang, L; Zhao, H, 2012) |
| "Phytic acid (PA) is a natural compound extracted from plant seeds, which shows certain antitumor activity and good bone targeting ability." | 1.91 | Phytic acid-modified manganese dioxide nanoparticles oligomer for magnetic resonance imaging and targeting therapy of osteosarcoma. ( Ding, J; Fan, J; Hu, R; Huang, R; Ju, Q; Li, R; Zhang, D, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ju, Q | 1 |
| Huang, R | 1 |
| Hu, R | 1 |
| Fan, J | 1 |
| Zhang, D | 1 |
| Ding, J | 1 |
| Li, R | 1 |
| Ren, L | 1 |
| Hong, ES | 1 |
| Mendoza, A | 1 |
| Issaq, S | 1 |
| Tran Hoang, C | 1 |
| Lizardo, M | 1 |
| LeBlanc, A | 1 |
| Khanna, C | 1 |
| Wang, L | 1 |
| Cheng, C | 1 |
| Zhao, H | 1 |
| Cui, H | 1 |
| Rao, PN | 2 |
| Murthy, SN | 2 |
| Muddukrishna, SN | 1 |
| Devaru, S | 2 |
| Radhakrishnan, ER | 1 |
| Bhargava, MK | 2 |
| Jogaiah, NH | 1 |
5 other studies available for phytic acid and Osteosarcoma
| Article | Year |
|---|---|
Phytic acid-modified manganese dioxide nanoparticles oligomer for magnetic resonance imaging and targeting therapy of osteosarcoma.
Topics: Bone Neoplasms; Humans; Hydrogen Peroxide; Magnetic Resonance Imaging; Manganese Compounds; Nanopart | 2023 |
Metabolomics uncovers a link between inositol metabolism and osteosarcoma metastasis.
Topics: Animals; Bone Neoplasms; Cell Line, Tumor; Heterografts; Humans; Inositol; Metabolomics; Mice; Neopl | 2017 |
[Anti-tumor effect of phytic acid on human osteosarcoma U2OS cells in vitro].
Topics: Antineoplastic Agents; Apoptosis; Bone Neoplasms; Cell Line, Tumor; Cell Proliferation; Humans; Oste | 2012 |
Comparison of technetium 99m-phytate and technetium 99m-sulphur colloid in primary bone tumours.
Topics: Adolescent; Adult; Bone Neoplasms; Female; Humans; Male; Organotechnetium Compounds; Osteosarcoma; P | 1990 |
Uptake of 99mTc-phytate in osteosarcoma cases.
Topics: Adult; Bone Neoplasms; Female; Humans; Liver Neoplasms; Organometallic Compounds; Organotechnetium C | 1989 |